Nav: Home

Vaccines save lives, but maintaining widespread coverage is essential

April 10, 2017

"A vaccine that remains in the vial is 0% effective even if it is the best vaccine in the world," states a new editorial by Emory Vaccine Center leaders in Proceedings of the National Academy of Sciences (PNAS). Although vaccines against preventable infectious diseases have dramatically reduced global mortality rates, the editorial asserts, maintaining community confidence in vaccination and ensuring widespread coverage is essential to the continued success of vaccines.

Rafi Ahmed, PhD, director of the Emory Vaccine Center, and Walter Orenstein, MD, associate director, emphasize that health care providers and community leaders must work together to increase vaccine confidence and acceptance by stressing the important health and economic benefits of vaccination both for those vaccinated and for their communities.

"In some sense, vaccines have become victims of their own success. Diseases that once induced fear and sparked desire for vaccines are now rare, and there is a false and dangerous sense of complacency among the public," say Orenstein and Ahmed.

Fears about vaccines and their side effects have been growing over recent years coupled with a lack of knowledge about the enormous health and economic benefits of vaccines, the authors say. Although multiple studies have found no support for vaccines as a cause of autism, and independent evaluation of the current immunization schedule has found it to be extremely safe, "translating the science into information capable of influencing vaccine skeptics has been difficult."

Orenstein and Ahmed cite a CDC report on 159 measles cases reported between January 4 and April 2, 2015 in which 68 of those with measles were unvaccinated and 29 of those cited philosophical or religious objections to vaccination. And a national survey found the percentage of U.S. pediatricians reporting parental vaccine refusals increased from 74.5 percent in 2006 to 87 percent in 2013. Globally, a 67-country survey of vaccine confidence reported an average of 5.8 percent of respondents (and a high of 15 percent in some countries) who were skeptical about the importance of vaccines.

The authors note several recent research studies on the benefits of vaccines: an analysis by the Centers for Disease Control and Prevention (CDC) of nine diseases that have been reduced by more than 90 percent and many that have either been eliminated or been reduced by 99 percent or more due to vaccines; research showing that vaccination has resulted in net economic benefits of almost $69 billion in the United States alone; and an economic analysis that estimates an investment of $34 billion for 10 vaccines in 94 low- and middle-income countries would result in $586 billion in reducing costs of illness and $1.53 trillion in overall economic benefits.

Vaccines not only provide individual protection, but also community protection by reducing the spread of disease within a population, say the authors. This particularly benefits vulnerable populations who cannot be vaccinated, including those too young for recommended vaccines, those with an inadequate response to vaccines (sometimes the elderly), or those who are immune-compromised and cannot be vaccinated. And although the focus of vaccines has been on children, there is an ongoing need to enhance immunization rates in adults, as vaccine-preventable diseases in adults are a global health problem and vaccine coverage rates for adults are much lower than those in children.

The National Vaccine Advisory Committee issued a report in 2015 with 23 recommendations to assure high levels of vaccine confidence, including creating a repository of evidence-based practices for informing, educating, and communicating with parents and others in ways that foster or increase vaccine confidence. Removing barriers to vaccination would also help boost vaccination rates, including providing recommended vaccines without cost to those who cannot afford them, and mandating vaccinations for children attending school.

"In summary," say Orenstein and Ahmed, "vaccines are some of the most effective and also cost-effective prevention tools we have. But vaccines that are not administered to persons for whom they are recommended are not useful. It is incumbent upon all of us who work in the healthcare setting, as well as community leaders, to stress to our friends and colleagues the importance of vaccination both for the individual vaccinated as well as for the communities in which the individuals live. Also critically important, there remains an urgent need for greater emphasis on research to develop vaccines for global diseases for which vaccines either do not exist or need improvement."
-end-


Emory Health Sciences

Related Vaccination Articles:

Researchers develop microneedle patch for flu vaccination
A National Institutes of Health-funded study led by a team at the Georgia Institute of Technology and Emory University has shown that an influenza vaccine can produce robust immune responses and be administered safely with an experimental patch of dissolving microneedles.
Rotavirus vaccination in infants and young children
Rotaviruses (RV) are the commonest cause of diarrhea in infants and young children worldwide.
Industry and occupation affect flu vaccination coverage
Not surprisingly, healthcare workers are almost twice as likely to get flu vaccines as those in other occupations.
Child's vaccination data handily available via Kasvuseula service
Parents can now follow their tots' vaccinations via the Kasvuseula online service, which provides analytical data on the child's growth.
Foot-and-mouth crises to be averted with vaccination strategy
Future outbreaks of foot-and-mouth disease (FMD) can be controlled effectively and quickly with vaccinations -- saving millions of pounds and hundreds of thousands of livestock -- according to research by the University of Warwick.
HPV prevalence rates among US men, vaccination coverage
Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various cancers, and a new study published online by JAMA Oncology estimates the overall prevalence of genital HPV infection in men ages 18 to 59.
Anesthetic cream best for relieving vaccination pain in infants
For babies under age one year, lidocaine cream, combined with a small amount of sugar given by mouth and infant soothing, can help relieve pain from routine vaccinations, according to a study in Canadian Medical Association Journal.
Measles prevention -- how to pull the trigger for vaccination campaigns?
Routine vaccination has greatly reduced measles deaths in recent years, but very high vaccination coverage is needed to prevent disease outbreaks.
Using satellite images to better target vaccination
Vaccination campaigns can improve prevention and control of disease of outbreaks in the developing world by using satellite images to capture short-term changes in population size.
Maternal vaccination again influenza associated with protection for infants
How long does the protection from a mother's immunization against influenza during pregnancy last for infants after they are born?

Related Vaccination Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...